Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04603547 · ClinicalTrials.gov registry record

Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy

A clinical trial of Neonatal Encephalopathy, sponsored by Brigham and Women's Hospital.

Active
Registry status
53
Enrollment target
1
Study location

NCT04603547 is a study of Neonatal Encephalopathy that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 53 participants, below the 128-participant average among 6 other Neonatal Encephalopathy trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04603547, a study of Neonatal Encephalopathy, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
53 participants
Enrollment target
1
Study location

Study Summary

The aim of our study is to evaluate the feasibility of applying transcutaneous CO2 monitoring (tcPCO2) in neonates receiving therapeutic hypothermia and to quantify the agreement between tcPCO2 and PCO2 in this population with or without respiratory support. Although, transcutaneous measurement of CO2 tension is the most commonly used non-invasive CO2 monitoring system in neonatal intensive care, to date tcPCO2 technique has not been evaluated systematically or used routinely in the intensive care of infants with neonatal encephalopathy receiving hypothermia treatment.

Conditions Studied

Neonatal Encephalopathy

Interventions

  • DEVICE Transcutaneous Carbon Dioxide Monitoring

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2019-09-28
Est. Completion 2027-12-30

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04603547

The ClinicalTrials.gov registry entry for NCT04603547 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 6 other Neonatal Encephalopathy trials with a reported enrollment target (59% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neonatal Encephalopathy appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Carbon Dioxide Monitoring is the first listed.

NCT04603547 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04603547 about?

NCT04603547 is a clinical study titled "Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy". The aim of our study is to evaluate the feasibility of applying transcutaneous CO2 monitoring (tcPCO2) in neonates receiving therapeutic hypothermia and to quantify the agreement between tcPCO2 and PCO2 in this population with or without respiratory support. Although, transcutaneous measurement of C...

What is the current status of trial NCT04603547?

This trial is currently active not recruiting. The enrollment target is 53 participants. The study started on 2019-09-28. Estimated completion is 2027-12-30.

What conditions does trial NCT04603547 study?

This clinical trial studies the following conditions: Neonatal Encephalopathy.

What interventions are being tested in trial NCT04603547?

The interventions under investigation include: Transcutaneous Carbon Dioxide Monitoring (DEVICE).

Who is sponsoring clinical trial NCT04603547?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04603547 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neonatal Encephalopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neonatal Encephalopathy

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.